Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06448026Phase 2Recruiting
Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2024-11-21
NCT06308575Phase 2Withdrawn
A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
Metastatic Olfactory NeuroblastomaRecurrent Olfactory Neuroblastoma
PrincipalinvestigatorStart date: 2024-11-01
NCT05363709Phase 2Withdrawn
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
HPVOropharyngeal Cancer
PrincipalinvestigatorStart date: 2023-10-18

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06448026Phase 2PrincipalInvestigator

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Recruiting
NCT06308575Phase 2PrincipalInvestigator

A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma

Metastatic Olfactory NeuroblastomaRecurrent Olfactory Neuroblastoma
Withdrawn
NCT05363709Phase 2PrincipalInvestigator

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

HPVOropharyngeal Cancer
Withdrawn

All 3 trials loaded